title: [A case of toxicity caused by drug interaction between capecitabine and phenytoin in patient with colorectal cancer].
abstract: We present a case of toxicity caused by a drug interaction between capecitabine and phenytoin (PHT). The drug combination elevated the plasma level of PHT in a patient on chemotherapy with capecitabine for colorectal cancer. Our patient was a 44-year-old woman diagnosed with epilepsy in her 20's, being treated with valproic acid (VPA) and PHT. Adjuvant chemotherapy with capecitabine began following surgery for colorectal cancer. Seven weeks later, she developed numbness, dizziness, dysarthria and difficulty walking, and was hospitalized for investigation. Her serum PHT level was elevated at 35. 1 μg/ mL. This case suggests that when capecitabine and PHT are coadministered, PHT levels should be monitored frequently, and that PHT dosage should be adjusted accordingly if it cannot be replaced by an alternative anticonvulsant.
authors.affiliation: Dept. of Pharmacy, Hyogo Prefectural Amagasaki Hospital.
authors.forename: Miyuki
authors.initials: M
authors.lastname: Sakurai
authors.forename: Kaori
authors.initials: K
authors.lastname: Kawahara
authors.forename: Rie
authors.initials: R
authors.lastname: Ueda
authors.forename: Eiji
authors.initials: E
authors.lastname: Fukui
authors.forename: Ryuhei
authors.initials: R
authors.lastname: Yamada
mesh_terms: D000328:Adult; D000927:Anticonvulsants / Q000009:adverse effects* / Q000097:blood / Q000627:therapeutic use; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects* / Q000097:blood / Q000627:therapeutic use; D000069287:Capecitabine; D015179:Colorectal Neoplasms / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D003841:Deoxycytidine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000097:blood / Q000627:therapeutic use; D004347:Drug Interactions; D004827:Epilepsy / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D005260:Female; D005472:Fluorouracil / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000097:blood / Q000627:therapeutic use; D006801:Humans; D010672:Phenytoin / Q000009:adverse effects* / Q000097:blood / Q000627:therapeutic use
chemical_list: D000927:Anticonvulsants; D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine; D010672:Phenytoin; D000069287:Capecitabine; D005472:Fluorouracil